A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Research Informatics Bookmark and Share

Division of Research Informatics

Ajay Shah, Ph.D.
Director

The Division of Research Informatics (RI) includes systems analysts, application developers/ software engineers, database administrators/architects, EDC/InTelescans group, and decision support services. The staff within RI is specially trained to focus on the information systems requirements unique to the research domain. RI combines the administrative and clinical care data collected during the normal course of patient care with protocol-specific data collected for research purposes and makes it available for use in outcome assessment and analysis.

The Division consists of three functional sections that include Clinical Research Informatics (CRI), Research Informatics Applications (RIA) , and Translational Research Informatics (TRI). It also operates the Cancer Center’s Research Informatics section of the Clinical Protocol & Data Management Core (CPDMC).
 
Research Informatics Applications
 
Srinivas Bolisetty
Director

Research Informatics Applications (RIA) seeks to employ emergent technologies and industry best practices to create integrated products that support the translational continuum. By taking an agile driven methodology, we are able to rapidly move requirements through a continuous integration pipeline - favoring frequent releases to minimize the time it takes for ideas to progress from concept to implementation while maximizing tolerance to change.

Services
 
  • Integrated Research Informatics Platform
  • In-house Applications
  • External Applications
  • Analysis, development, and integration of research support applications
  • Rapid Prototyping
  • Web & Mobile Development
     
Clinical Research Informatics (CRI)

Gabe Peterson
CRI Director

Clinical Research Informatics (CRI) enables the effective and efficient execution of clinical research -- including clinical trials and outcomes research – by applying the science of information management.
 
The key strategic goal of CRI is to build a world-class clinical research informatics infrastructure by implementing best-in-class vendor solutions where available and developing innovative solutions that give City of Hope researchers a competitive advantage. To advance this goal,CRI led the selection and implementation of the best-in-class Electronic Data Capture (EDC) solution for clinical trials with the Medidata EDC, and deployed the Clinical Research Portal business intelligence solution to help clinical researchers translate their data into decisions.

Services
 
  • Clinical Trials Data Capture and Management
  • Observational Research Data Capture and Management
  • Clinical Research Decision Support
 
Research Informatics Architecture
 
Abdul Malik Shakir
Director

Services
  • Research Informatics Platform Architecture
  • Data Architecture
  • Enterprise Data Warehouse
     
Translational Research Informatics Core (TRIC)
 
Mike Chang, Ph.D.
TRI Director

Translational Research Informatics (TRI) strives to empower ground breaking research from basic bench research to clinical research and back. Our goal is to provide contemporary technological solutions to nimbly and specifically support information capture, management and exchange across the Translational Research Space.
 
Our approach is to provide support and service at the individual lab level. Introducing new information technology solutions to help make gathering and visualization of experimental data more facile and at the same time, to optimize and make the process of scientific research more efficient. While our target clients are in the translational research space, we will develop, in time, an information infrastructure partnered with Clinical Research Informatics (CRI) and Bioinformatics that will spark and enable collaborations across basic and clinical research.
 
Services
 
  • Translational Research Experimental Data Capture, Management and Analyses
  • Systems and Process Analyses for Translational Research
  • Workflow/process analyses, optimization and automation.
  • Integrated Inventory & Sample management
 

Research Informatics

Division of Research Informatics

Ajay Shah, Ph.D.
Director

The Division of Research Informatics (RI) includes systems analysts, application developers/ software engineers, database administrators/architects, EDC/InTelescans group, and decision support services. The staff within RI is specially trained to focus on the information systems requirements unique to the research domain. RI combines the administrative and clinical care data collected during the normal course of patient care with protocol-specific data collected for research purposes and makes it available for use in outcome assessment and analysis.

The Division consists of three functional sections that include Clinical Research Informatics (CRI), Research Informatics Applications (RIA) , and Translational Research Informatics (TRI). It also operates the Cancer Center’s Research Informatics section of the Clinical Protocol & Data Management Core (CPDMC).
 
Research Informatics Applications
 
Srinivas Bolisetty
Director

Research Informatics Applications (RIA) seeks to employ emergent technologies and industry best practices to create integrated products that support the translational continuum. By taking an agile driven methodology, we are able to rapidly move requirements through a continuous integration pipeline - favoring frequent releases to minimize the time it takes for ideas to progress from concept to implementation while maximizing tolerance to change.

Services
 
  • Integrated Research Informatics Platform
  • In-house Applications
  • External Applications
  • Analysis, development, and integration of research support applications
  • Rapid Prototyping
  • Web & Mobile Development
     
Clinical Research Informatics (CRI)

Gabe Peterson
CRI Director

Clinical Research Informatics (CRI) enables the effective and efficient execution of clinical research -- including clinical trials and outcomes research – by applying the science of information management.
 
The key strategic goal of CRI is to build a world-class clinical research informatics infrastructure by implementing best-in-class vendor solutions where available and developing innovative solutions that give City of Hope researchers a competitive advantage. To advance this goal,CRI led the selection and implementation of the best-in-class Electronic Data Capture (EDC) solution for clinical trials with the Medidata EDC, and deployed the Clinical Research Portal business intelligence solution to help clinical researchers translate their data into decisions.

Services
 
  • Clinical Trials Data Capture and Management
  • Observational Research Data Capture and Management
  • Clinical Research Decision Support
 
Research Informatics Architecture
 
Abdul Malik Shakir
Director

Services
  • Research Informatics Platform Architecture
  • Data Architecture
  • Enterprise Data Warehouse
     
Translational Research Informatics Core (TRIC)
 
Mike Chang, Ph.D.
TRI Director

Translational Research Informatics (TRI) strives to empower ground breaking research from basic bench research to clinical research and back. Our goal is to provide contemporary technological solutions to nimbly and specifically support information capture, management and exchange across the Translational Research Space.
 
Our approach is to provide support and service at the individual lab level. Introducing new information technology solutions to help make gathering and visualization of experimental data more facile and at the same time, to optimize and make the process of scientific research more efficient. While our target clients are in the translational research space, we will develop, in time, an information infrastructure partnered with Clinical Research Informatics (CRI) and Bioinformatics that will spark and enable collaborations across basic and clinical research.
 
Services
 
  • Translational Research Experimental Data Capture, Management and Analyses
  • Systems and Process Analyses for Translational Research
  • Workflow/process analyses, optimization and automation.
  • Integrated Inventory & Sample management
 
Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media

For media inquiries contact:

Dominique Grignetti
800-888-5323
dgrignetti@coh.org

 

For sponsorships inquiries please contact:

Stefanie Sprester
213-241-7160
ssprester@coh.org

Christine Nassr
213-241-7112
cnassr@coh.org

 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 
NEWS & UPDATES
  • September is Prostate Cancer Awareness Month. Here, Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Services at City of Hope, explains the importance of understanding the risk factors for the disease and ways to reduce those risks, as well as overall prostate health. “Wha...
  • ** Learn more about prostate cancer risk, plus prostate cancer research and treatment, at City of Hope. ** Learn more about getting a second opinion at City of Hope by visiting us online or by calling 800-826-HOPE (4673). City of Hope staff will explain what’s required for a consult at City of Hope and he...
  • Childhood cancer survival rates have increased dramatically over the past 40 years. More than 80 percent of children with cancer now survive five years or more, which is a tremendous feat. Despite the survival rate increase, cancer continues to be the No. 1 disease killer and second-leading cause of death in ch...
  • Although a stem cell transplant can be a lifesaving procedure for people diagnosed with a blood cancer or blood disorder, the standard transplant may not be appropriate for all patients. This is because the conditioning regimen (the intensive chemotherapy and/or radiation treatments preceding the transplant) is...
  • Brain tumor removal would seem to be the obvious course of action in the wake of a brain tumor diagnosis, but that’s not always the case. Some tumors are too difficult for many surgeons to reach or too close to areas that control vital functions. Removing them just proves too risky. A new device being con...
  • Hijacking the same sorts of viruses that cause HIV and using them to reprogram immune cells to fight cancer sounds like stuff of the future. Some scientists believe that the future is closer than we think – and are now studying the approach in clinical trials at City of Hope. Immunotherapy is a promising approa...
  • Nausea is the one of the most well-known, and dreaded, side effects of cancer treatment — and with good reason. Beyond the quality-of-life issues that it causes, severe nausea can prevent patients from receiving enough nutrients and calories at a time when they need every edge they can get. A few simple actions...
  • With Labor Day just around the corner, summer is on its way out. But just because summertime is ending doesn’t mean we can skip sunscreen. Protection from ultraviolet (UV) radiation is needed all year round. Exposure to UV radiation — whether from the sun or from artificial sources such as sunlamps used i...
  • Undergoing reconstructive surgery may seem like a forgone conclusion for survivors of breast cancer, but that doesn’t appear to be the case. A new study has found that most breast cancer survivors who undergo a mastectomy decide against surgical reconstruction of their breasts. The reasons for such a deci...
  • Nearly four decades ago, City of Hope began its bone marrow transplant program. Its first transplant reunion celebration was a single patient and his donor, also his brother. This year, City of Hope welcomed hundreds of hematopoietic cell transplant (HCT) recipients to the annual bone marrow transplant/HCT reun...
  • The burgeoning type 2 diabetes epidemic casts a pall over the health of America’s public. New research now shows the looming threat is getting worse. Much worse. A diabetes trends study published earlier this month in the Lancet Diabetes and Endocrinology by researchers at the federal Centers for Disease Contro...
  • An aspirin a day might help keep breast cancer away for some breast cancer survivors, a new study suggests. Obese women who have had breast cancer could cut their risk of a recurrence in half if they regularly take aspirin or other nonsteroidal anti-inflammatory drugs, called NSAIDs, report researchers from the...
  • Christine Crews isn’t only a fitness enthusiast, she’s also a personal trainer and fitness instructor. Being active defines her life. So when she was diagnosed with bladder cancer at age 30, she decided she absolutely couldn’t let the disease interfere with that lifestyle. And it didn’t. For t...
  • Cancer treatment and the cancer itself can cause changes in your sense of taste or smell. These side effects typically subside after treatment ends, but there are ways to help alleviate those bitter and metallic tastes in your mouth. Here are tips from the National Cancer Institute to help keeps tastes and food...
  • Immunotherapy — using one’s immune system to treat a disease — has been long lauded as the “magic bullet” of cancer treatments, one that can be more effective than the conventional therapies of surgery, radiation or chemotherapy. One specific type of immunotherapy, called adoptive T cell thera...